USP

As manufacturers, regulators, distributors, health systems, and pharmacopeias work to strengthen medicines supply chain resilience, one thing is clear: better decisions require better visibility. At #CPHIMilan, Ronald Piervincenzi and Michael Levy discuss why data transparency and collaboration are essential to identifying vulnerabilities, mitigating risks, and helping ensure patients have access to the medicines they need. USP has solutions like the Medicine Supply Map and MethodConnect to help advance medicine quality, strengthen supply chain visibility, and support more informed decision-making. Through the USP Resiliency Center, we are working with stakeholders around the world to strengthen resilience for people everywhere. At CPHI Milan? Visit USP at Booth #16F30 to continue the conversation.

Stronger medicine supply chains begin with better visibility—and the right conversations. Meet USP at CPHI Milan, October 6–8, 2026. If your organization is looking to identify medicine supply chain vulnerabilities, assess risk or strengthen resilience, connect with the USP team. Visit booth #16F30 to discuss your supply chain priorities with our experts and explore how data-driven insights can support more informed decisions and a reliable supply of quality medicines. Schedule a meeting with USP: https://lnkd.in/dPbyxyAR

Analytical confidence is stronger when backed by established standards and methods. Explore the USP Endocrine Portfolio of monographs and related USP Reference Standards. ✓ Support clearer analytical results with expert-reviewed USP–NF methods. ✓ Draw on monograph methods rigorously reviewed by independent scientists before becoming official. ✓ Support inspection and submission clarity with standards recognized and cited by regulators globally. ✓ Help maintain consistency across global development and manufacturing programs.

GLP‑1 receptor agonists are transforming metabolic care—but they also raise the bar for analytical rigor and quality standards. USP supports the GLP‑1 peptide ecosystem with reference standards and materials across established molecules such as Exenatide, Liraglutide, and Semaglutide, alongside emerging GLP‑1 therapies. As this class of peptide therapeutics continues to expand, USP helps enable confidence through globally recognized standards that support quality across the lifecycle.

Seeking #dietarysupplement stakeholder feedback! Help shape USP Standards by sharing your feedback on proposed dietary ingredient and dietary supplement monographs today: Broccoli Seed Dry Extract Choline Bitartrate Choline Chloride Choline Citrate Guarana Seed Guarana Seed Dry Extract Guarana Seed Powder Pyrroloquinoline Quinone Disodium Red Yeast Dry Extract Red Yeast Rice Powder Submit your comments by September 30, 2026

Calling all #dietarysupplement and #dietaryingredient stakeholders! Participate in USP’s standards development process by submitting your comments on proposed dietary ingredient and dietary supplement monographs today: Broccoli Seed Dry Extract Choline Bitartrate Choline Chloride Choline Citrate Guarana Seed Guarana Seed Dry Extract Guarana Seed Powder Pyrroloquinoline Quinone Disodium Red Yeast Dry Extract Red Yeast Rice Powder